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Abstract
Transcutaneous delivery of vaccines to specific skin dendritic cells (DC) subsets is foreseen as a promising strategy to induce
strong and specific types of immune responses such as tolerance, cytotoxicity or humoral immunity. Because of striking
histological similarities between human and pig skin, pig is recognized as the most suitable model to study the cutaneous
delivery of medicine. Therefore improving the knowledge on swine skin DC subsets would be highly valuable to the skin
vaccine field. In this study, we showed that pig skin DC comprise the classical epidermal langerhans cells (LC) and dermal DC
(DDC) that could be divided in 3 subsets according to their phenotypes: (1) the CD163
neg/CD172a
neg, (2) the
CD163
highCD172a
pos and (3) the CD163
lowCD172a
pos DDC. These subtypes have the capacity to migrate from skin to lymph
node since we detected them in pseudo-afferent lymph. Extensive phenotyping with a set of markers suggested that the
CD163
high DDC resemble the antibody response-inducing human skin DC/macrophages whereas the CD163
negCD172
low
DDC share properties with the CD8
+ T cell response-inducing murine skin CD103
pos DC. This work, by showing similarities
between human, mouse and swine skin DC, establishes pig as a model of choice for the development of transcutaneous
immunisation strategies targeting DC.
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Introduction
Vaccines targeting skin, through intradermal or epicutaneous
delivery, present several advantages compared to the vaccine given
intramuscularly, such as: dose sparing [1] and better activation of
cytotoxic and mucosal responses [2,3]. Current knowledge supports
that optimal induction of immune responses depends on the dendritic
cell (DC) subtypes that are targeted by vaccines. Thus the
identification of the DC subtypes in the skin and the analysis of
their specialized function in immunity are key steps in the
development of cutaneous delivered vaccines. Most information on
skin DC has been obtained in the mouse model (for review see [4]).
Mouse epidermis contains a unique DC subset, the Langherans cells
(LC), that can be identified in the mouse by their high expression of
Langerin(CD207).SomemigratingLC,enrouteforthelymphnodes
(LN),arealsofoundinthedermis[5].TheroleofLCisstillunclearin
the mouse, but converging results suggest that they behave as
immunoregulatory cells [6,7,8]. Mouse dermal DC (DDC) comprise
four distinct subsets, the discrete CD207
posCD172a
negCD103
pos,
the CD207
posCD172a
posCD103
neg, CD207
negCD172a
posCD11b
high
and CD207
negCD172a
posCD11b
neg DDC subsets [5]. The
CD207
posCD172a
negCD103
pos DDC have received much attention
recently as they play a key role in cross-presentation for tolerance
induction and in mounting a CD8
+T cell immune response [5,8],[9].
Although playing a major role in specific immune responses, they
represent less than 5% of the DDC [5,10], but 13% of the skin
draining LN DC [5].
Much less data are available for the human skin DC. Human
CD207
high LC have been identified in epidermis, but contrary to
mouse, they were described as the most efficient skin DC subset to
expand antigen specific CD8
+ T cells by antigen cross-presenta-
tion [11]. Besides, two DC subsets (CD14
pos and CD1a
pos DDC)
were distinguished in the human dermis [11,12], but they do not
share cell surface phenotype with the mouse DDC. For instance,
the CD207 marker was not found expressed by human DDC. The
minor CD14
pos DDC subset expresses several macrophagic
markers such as CD163, DC-Sign/CD209 and the mannose-
receptor/CD206, and was found to prime CD4
pos T cells into cells
that induce isotype switching in B cells. The largely represented
CD1a
pos DDC subset was revealed to activate CD8
+ T cells better
than CD14
pos DC but less efficiently than LC.
Results on human skin DC functions were generated in vitro,
whereas the mouse DC functional data were obtained in vivo.
These different experimental approaches may explain the
discordant functional results obtained from the two species.
Alternatively, intrinsic differences in the mouse and human skin
structures such as the hairiness and the stratum corneum thickness
might be associated to evolutionary divergences in DC subpop-
ulation roles. Evaluation of novel vaccine strategies via the skin
would thus greatly benefit from a more relevant animal model that
would permit in vivo investigation. Pig skin shares strong
histological similarities with human skin, such as low hairiness,
thick strateum corneum with similar lipid composition [13], and
dermis structure [14]. CD207
high LC have been identified in pig
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skin explants expressed CD1, CD172a, MHC-II and CD80/
CD86 [15]. Finally, pig is a large mammal which permitted us to
adapt for the first time pseudo afferent catheterism to swine skin
lymph collection [18].
In this report, we thoroughly described and analyzed 4 swine
DC subsets in epidermis, dermis and lymph, and we suggested
possible correspondences with mouse and human skin DC. This
provides a first analytical and dynamic picture on the swine skin
DC establishing pig as a relevant model to study skin DC subsets
role in immune responses and to develop novel vaccine strategies.
Results
Selection of the markers used for the discrimination of
DC subtypes
For FACS gating of DC from skin and lymph, we used the most
widely recognized phenotypic definition of DC, as being large,
MHC-II
high cells. We first checked, using MHC-II/CD14 staining,
that CD14
high dermal macrophages were not present in the MHC-
II
high gate; similarly MHC-II/CD21 staining assured us that
CD21
pos dermal B lymphocytes were absent from the DC gate
(Figure 1). We then tested a panel of antibodies available in pig
allowing the detection of several proteins previously described on
mouse and human DC (Figure 1). These markers were CD163 (the
scavenger receptor of haemoglobin-haptoglobin-complexes),
CD172a/Sirpa, the ligand of CD47, CD11R3, a possible pig
equivalent to CD11b [19], CADM1/SYNCAM, described as
differentially expressed in cross-presenting DC in mouse [20] and
sheep [21], and having a potential role in DC/CD8 T cells
interaction [22], [23], CD16/FccR3A, CD206/Mannose Recep-
tor, CD207/Langerin and CD209/DC-Sign. The expression of
each antigen was first tested on DC extracted from dispase-split
epidermal and dermal sheets with or without collagenase digestion.
Indeed, the use of collagenase allowed the collection of up to 30
times more DDC. We observed no variation, nor in percentage of
expressing cells, neither in expression intensities of all the markers
tested at the exception of CadM1, whose expression was totally
abrogated by the collagenase treatment (data not shown). Thus
CadM1 expression was analysed on DC extracted from split
epidermis and dermis in absence of collagenase.
DDC presented bi-modal expression patterns of CD172a,
CD16, CD206, CD207/Lang and CD209/DC-Sign, an even
more complex expression of CD163, which discriminate 3
different DDC populations (negative, low and high CD163
expressing DC), a homogenous expression of CD11R3 and almost
no CadM1 detection. Epidermal DC were homogenous in the
expression of all the markers tested, at the exception of CD209,
which discriminated about 5% of positive cells from the main
CD209
neg population. We observed no expression of CD163 and
CD206; low to null expression of CD16, depending of the animal;
and a strikingly high expression of CD207.
In order to analyze the skin DC that migrate in lymph, lymph
duct catheterism was conducted. FSC/SSC
high and MHC-II
high
cells, represented around 1% of the total lymph cells. We next
characterized lymph DC, they presented similar complex
expression patterns as DDC for all the tested antigens, at the
exception of CD209 which was not expressed on lymph DC.
Definition and phenotype of four DC subtypes
The complex marker expression patterns found on lymph and
dermal DC suggested the existence of DC subpopulations. In
human skin, CD163 has been described on a macrophage-like
DDC subpopulation [11,12,24] whereas CD172a
neg DC have
been described in several species as endowed with cross-
presentation capacities [5,8,9,21]. We thus chose to phenotypically
characterized DC subpopulations distinguished by the expression
of CD163 and CD172a (Figure 2).
Using CD163 and CD172a, 4 subpopulations could be
segregated in the dermis: the quantitatively minor population (1)
CD163
negCD172a
neg (9+/- 2%), the population (2) CD163
highC-
D172a
pos (25+/- 3%), the population (3) CD163
lowCD172a
pos,
constituting the majority of the DDC (47+/- 7%) and the
population (4) CD163
negCD172a
pos DDC (11+/- 5%). Population
(1) was negative for the majority of the markers tested, with the
exception of a bimodal expression of CD11R3 (CD11R3
neg and
CD11R3
low) and CadM1 (CadM1
neg and CadM1
low) and a minor
CD209
pos subpopulation. The expression of CadM1 in this
subpopulation (1) is in agreement with the described CadM1
pos/
CD172a
neg phenotype of cross-priming DC in mouse spleen [20]
and sheep afferent lymph [21]. The CD163
high DDC population
(2) presented a strikingly high expression of CD16 and was positive
for CD206 and CD209, in agreement with a ‘macrophage like’
phenotype [11,12,24]. The DDC population (3) was CD16
low and
presented a heterogeneous expression of CD207/Langerin.
Finally, in the dermis the last population (4) highly expressed
Figure 1. Phenotyping of swine DC in skin and afferent lymph. FACS analysis of DC from dermis, epidermis and pseudo-afferent iliac lymph.
Skin biopsies were first split in epidermis and dermis by dispase digestion of the basal layer, before overnight collagenase digestion of the dermis.
Lymph DC were enriched by density gradient before staining. Dot-plots represent the gating strategy (FSC
high/MHC-II
high cells) used to electronically
isolate DC from the different tissues. Histograms depict isotype control (plain histograms) versus indicated marker expression (bold, open histograms)
and are representative of at least 3 independent experiments on 3 different animals.
doi:10.1371/journal.pone.0016320.g001
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namely Langerhans cells (LC), constituting the vast majority of the
epidermal DC (95+/- 3%). They expressed the same levels of
CD163 and CD172a than the dermal DC population (4).
Moreover, with the exception of CD16 which is lower, and of
CadM1 which is not expressed in the DDC population (4), LC and
DDC population (4) expressed the same levels of the other markers
tested, pleading for a common epidermal origin of these two DC
populations.
In the lymph, the same 4 DC subpopulations were observed,
however their distribution was quite different from skin (Table 1)
since the minor dermal DC population (1) CD163
neg/CD172a
neg
represented 26+/- 3% of the lymph DC, whereas the subtype (2)
CD163
high/CD172a
pos, well represented in the dermis, represent-
ed only 2+/- 2% of the lymph DC. The lymphatic distribution of
these two subpopulations is significantly different from the
distribution of their skin counterparts (p,0.001). The lymphatic
distributions of populations (3) and (4) were not different from skin
(respectively 52+/- 8% and 13+/- 8%).
Lymph DC subpopulations expressed mostly the same markers
than their skin counterparts. The most striking similarities were: i)
the CadM1 expression of the CD172a
neg DDC population (1), ii)
the CD16
high profile of the CD163
high DDC population (2), iii) the
CD207
high expression of the DDC (4)/LC populations. The main
differences between lymph and skin DC were the higher expression
of CD16 on CD163
low lymph DC (populations (3) and (4))
compared to their skin counterparts, a higher general expression
of CD206 and a more homogenous weak to null expression of
CD209 in all the lymph DC subpopulations (Figure 2).
In order to demonstrate that lymph DC subpopulations came
from skin territories, we proceeded to skin FITC painting and we
observed, after two days, lymph DC having incorporated FITC.
The same lymph DC subpopulations (1), (2), (3) and (4) were
observed in FITC
pos DC than in FITC
neg DC, although not
exactly in the same proportions (Figure 3).
Thus, as emphasized in Table 1, we described here 4 different
skin DC subtypes and followed their in vivo migration from skin to
LN, through the afferent lymphatic.
Figure 2. Characterization of the 4 DC subsets present in skin and lymph. FACS analysis of DC from dermis, epidermis and pseudo-afferent
iliac lymph. DC were gated using the same criterions as in Figure 1 (FSC
high/MHC-II
high). The expressions of the markers identified in Figure 1 were
differentially reexamined on lymph and dermal DC subpopulations characterized as CD163
neg/CD172a
neg (1), CD163
high/CD172a
pos (2), CD163
low/
CD172a
pos (3), and CD163
neg/CD172a
pos (4). In epidermis, Langerhans cells (LC) were retrieved in the same gate than population (4) from dermis and
lymph. Histograms depict isotype control (plain histograms) versus indicated marker expression (bold, open histograms) and are representative of at
least 3 independent experiments on 3 different animals.
doi:10.1371/journal.pone.0016320.g002
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%( +/- SD) CD11R3 CD16/FccR3 CD206/MR CD207/Lang CD209/DCSign CadM1/SYNCAM
1 CD163
neg/CD172a
neg Dermis 9% (+/- 2%) * ++ and - - - - - ++ and -
Lymph 26% (+/- 3%) * ++ /- - - +/- ++
2 CD163
high/CD172a
pos Dermis 25% (+/- 3%) * +++ + +++ ++ - ++ +/-
Lymph 2% (+/- 2%) * +++ + +++ + - +/- -
3 CD163
low/CD172a
pos Dermis 47% (+/- 7%) +++ + - + and - - -
Lymph 52% (+/- 8%) ++ ++ + + and - +/- -
4/LC CD163
neg/CD172a
pos Epidermis 95% (+/- 3%) +++ ++ - +++ + and - ++
Dermis 11% (+/- 5%) +++ + - +++ --
Lymph 13% (+/- 8%) ++ ++ + + +++ +/- ++
Four DC subpopulations have been characterized in lymph and skin. Percents +/- standard deviation (SD) represent the mean of at least 4 experiments on different
animals.
*Represent significant differences (student T test p,0.001) in the percentage of DC subpopulations between dermis and lymph. Expression intensity for each antigen is
depicted from (++++): Highly expressed, to (+/-): Very low expression, to (-): No expression at all. (+ and -) means that there is a bimodal expression of the antigen. The
markers allowing the best discrimination between DC subtypes are highlighted in bold.
doi:10.1371/journal.pone.0016320.t001
Figure 3. Skin FITC painting attests that all the lymph DC subtypes migrate from skin. Skin FITC painting allows the detection of DC
migrating from skin to lymph. FITC at 1 mg/ml in acetone/dibutylphtalate (V/V) was applied on the leg of the animal, lymph was collected before
painting and 2 days after painting, and lymph cells were then stained for MHC-II, CD172a and CD163. DC were gated using the same criterions as in
Figure 1 (FSC
high/MHC-II
high). FITC
neg and FITC
pos DC subpopulations are depicted. Data are representative of two independent experiments.
doi:10.1371/journal.pone.0016320.g003
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In confocal experiments, anti-CD1 antibodies appeared to
more distinctly stain DC than anti-MHC-II antibodies. Moreover
we and others [15] have checked that MHC-II and CD1
molecules were co-expressed on the vast majority of skin cells.
We thus used CD1 instead of MHC-II to detect skin DC in situ.
CD1 staining allowed the unambiguous distinction between skin
DC and macrophages, since preliminary experiments showed that
skin macrophages were CD1
neg/CD14
high whereas skin DC were
CD1
pos/CD14
neg/low (data not shown). Using CD1 or MHC-II as
DC markers, we were not able to distinguish CD172a
neg from
CD172
pos DC (Figure 4A), however CadM1 expression
(Figure 4H), a signature of CD172a
neg DC, was observed in the
dermis. CD11R3 appears highly expressed on DDC and on LC
(Figure 4B). As expected from flow cytometry analysis CD163,
CD206 and CD209 were observed on a fraction of DDC, but not
on LC (Figures 4C, E, G). CD16 was expressed on a DDC
subpopulation, but also, at a weaker level, on LC (Figure 4D). As
expected, CD207 was expressed on LC, but also on some DDC
(Figure 4F). Finally CADM1 expression appeared in the
epidermis on cells along the basal layer, corresponding to
undifferentiated keratinocytes, but also on LC and on some
DDC (Figure 4H). In addition, different staining combinations
confirmed that CD163
pos DDC expressed CD16, CD206 and
CD209, but neither CD207 nor CadM1 (data not shown). Thus
we were able to detect in situ the 4 skin DC subpopulations defined
by Facs analysis. Except for the LC, present in the epidermis, no
preferential localization of the 3 DDC subpopulations in upper or
lower dermis was observed.
CD172a
neg/CD163
neg DDC and lymph DC transport
apoptotic bodies
In rat mesenteric lymph [25] and sheep oro-nasal and skin
lymph [26], a CD172a
neg DC subset has been described that
contains cytoplasmic apoptotic DNA. The pig skin derived
CD172a
neg DC subtype (1) appeared CD11R3
lowCD163
negCD16-
negCD207
negCD209
neg and strikingly CADM1
pos (Figure 2). It
could be detected both in the dermis and the afferent lymph. We
thus tested these DC for the presence of cytosolic apoptotic bodies.
TUNEL
pos cytoplasmic inclusions were mostly found in the
CD172a
neg DC from lymph and dermis (Figure 5). Moreover
CD163 and TUNEL co-stainings showed the presence of
apoptotic bodies uniquely into CD163
neg DC from lymph and
dermis (data not shown). Finally no TUNEL staining was observed
in LC (data not shown). These results indicate that transportation
of apoptotic bodies from skin to lymph is a specific property of the
CD172a
negCD163
neg dermal DC subpopulation in pig.
Discussion
Using two markers selected for human and murine DC
characterization, CD163 and CD172a, we described four DC
subpopulations present in pig skin. Thanks to the new surgical
protocol we developed, we were able to collect pseudo afferent
Figure 4. In situ skin DC phenotyping. Sections of normal swine skin were acetone/methanol fixed and stained for the indicated specificity
(green) and CD1 (red). A. CD172a, B. CD11R3, C. CD163, D. CD16, E. CD206, F. CD207, G. CD209, H. CADM1. Antibodies used are described in Materials
and Methods. Images are representative of at least 5 pictures from different regions of biopsies from at least 3 different animals, independently
stained. Objective used 40x oil immersion. E: Epidermis, D: Dermis, Scale bars =10 mm.
doi:10.1371/journal.pone.0016320.g004
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subsets we described did have the capacity to migrate in the
lymph. Our goal was to define specific DC subtypes that could be
targeted in skin vaccination. We thus considered of great
importance to ascertain that each of these subtypes had the
capacity to migrate through the lymph toward the LN, where they
would eventually encounter the naı ¨ve lymphocytes in order to
mount the desired immune response.
We more precisely characterized the already described [17]
swine epidermal LC as CD163
negCD172a
posCD207
high which
allowed us to identify their lymph-migrating counterpart,
representing 11% of total afferent lymph DC. This subpopulation
was also observed in the dermis, likely representing LC en route
for the lymphatic. We defined three other DDC subpopulations:
the CD163
negCD172a
neg DDC subtype (1) transports apoptotic
bodies and is observed in equivalent proportion (,20%) in swine
and sheep skin lymph [26]. Its mouse (CD172a
neg/CD103
pos) [5],
human (CD172a
neg/BDCA3
pos) [20] and sheep (CD172a
neg/
CD26
pos) [21] counterparts are endowed with unique cross-
priming capacities. Of note, the human BDCA3
pos DC have been
observed in blood but have not yet been described in skin.
Unfortunately neither CD103 nor BDCA3 nor CD26 antibodies
are available in pig. CD163
negCD172a
neg DDC subtype (1) does
not express CD207/Lang, at the difference with mouse CD172a-
neg/CD103
pos DC, whereas CD207 expression in BDCA3
pos
human DC is still controversial [20,27]. Conversely the sub
population (3) defined as CD163
lowCD172a
pos presents a variable
proportion of CD207
low cells. Except for CD207 and CD11R3,
this sub population does not express other tested markers. Finally
the CD163
highCD172a
pos DDC population (2) expresses macro-
phagic markers such as CD209 and CD206 and might represents
the equivalent of CD14
posCD163
pos human DDC [11,12,24].
Our unique pseudo-afferent catheterism technique allowed us
to identify lymphatic counterparts to the dermal subpopulation
we described. We can not rule out the possibility that these skin
DC subpopulations modify their phenotype upon migration,
however using a combination of several different markers present
both on cutaneous and lymphatic DC, populations 1, 2 and 4
can be unambiguously distinguished in these two tissues.
Population (1) is CD172a
neg/CD163
neg/CD16
neg/CD206
neg/
CadM1
pos, population (2) is CD163
high/CD16
high/CD206
high
whereas, LC/population (4) is CD172a
pos/CD163
neg/CD16
pos/
CD207
high/CadM1
pos; in addition FITC painting revealed that
at least one part of these lymphatic DC subpopulations originate
from skin. Altogether these parameters plead for the fact that skin
DC subpopulations 1, 2 and 4 might be the actual precursors of
their lymphatic counterparts. We observed that the CD172a
neg
population (1) is overrepresented in afferent lymph compare to
dermis. Interestingly, a higher migration rate has been proposed
to explain the higher percentage of their mouse (CD172a
neg/
CD103
pos) counterpartinLN (13%of theDC) thaninskin(5%of
the DDC)[5]. Conversely, in swine, the CD163
high DDC
population (2) is under represented in afferent lymph. These
results might be interpreted by differences in their residence time
in the tissue at steady state, the CD163
high DDC having a low
turn over whereas the CD172a
neg DDC would have a more rapid
turn over in the normal skin. It is important to note that we
analyzed lymphatic DC present in the lymph more than 10 days
post-surgery to eliminate the consequences of inflammation due
to surgery. Conversely this work was performed on healthy
conventional pigs, which might imply some background inflam-
mation. Nevertheless, we consider these conditions comparable
to what can be obtained when studying human skin samples
[11,12].
Figure 5. CD172a
neg DC from lymph and dermis contain apoptotic bodies. Lymph DC were partially enriched by low density gradient. Skin
biopsies were first split in epidermis and dermis by dispase digestion, before overnight collagenase digestion of the dermis. Dermal DC were then
enriched by Ficoll gradient. DC were further purified using MHC-II and magnetic beads staining followed by magnetic separation. Lymph and Dermis
DC were then cyto-centrifuged, fixed in PFA and reacted with anti-MHC-II (red) and anti-CD172a mAb (blue). Cells were further labelled for apoptotic
DNA by the TUNEL method (green). Data are representative of 3 independent experiments.
doi:10.1371/journal.pone.0016320.g005
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and to find their lymph migrating steady state counterparts. This
first step accomplished, we are currently devising a transcriptomic
study of the different swine skin subpopulations described here, in
order to confirm their assignment to their murine, human [20] and
sheep [21] counterparts. Moreover the definition of swine skin DC
subsets and their assignment to their mouse counterparts will allow
the design of subset targeting vaccines by the use of chimeric
antibodies targeted to specific DC subsets. Antibody-based DC
targeting has recently been shown to be exceptionally efficient in
mouse models after a single vaccination (for review see [28]). For
instance, in mice, targeting CD11b
high DC using DCIR2 [29],
Dectin-1 [30] or CIRE/mDC-Sign [31] induced CD4 responses
whereas targeting CD8a
pos spleen DC using anti-DEC-205 [29] or
Clec9A [31] induced CD8 responses. Our description of swine DC
subsets and the transcriptomic work in progress, will lead to the
determination of target antigens specifically expressed on swine
DC subtypes, allowing the development of this technology in swine
which, in addition to its great interest in animal health, would be
an important proof of principle for its translation in human
medicine.
In conclusion, this study describes a skin DC network in swine
similar to that of mouse and human. Finally the skin structure
similarities between man and pig, now comforted by immunolog-
ical homologies, allow us to propose the use of pig as a model of
choice for the expanding field of transcutaneous vaccinations.
Materials and Methods
Ethics statement
This study was carried out under licenses from the Direction of
the Veterinary Services of Versailles (accreditation nuA78-93,
A78-15, A78-730). This study was approved by the Regional Paris
South Ethics committee (nu08-001).
Pseudo afferent lumbar lymph duct catheterism in
miniature pigs
Pseudo-afferent lumbar lymph duct catheterization was per-
formed in two steps. First, LN draining the flank, hindquarters,
and inguinal areas were surgically resected. Two months later,
after lymph vessel healing, a retro-peritoneal surgery was
performed for inserting a silicone catheter (4 french, Nutricath
bSQ, Vygon, Ecouen, France) in the lumbar trunk. The catheter
was led out through a skin opening into a flask containing 500
units heparin. To facilitate lymph draining, pigs were left free in
2m
2 cages. Pigs received one intramuscular injection of
terramycin (20 mg/kg, Pfizer, Paris, France) and of low molecular
weight flunixin (Finadyne, 1 mg/kg, Schering Plough, Levallois
Perret, France). Heparin (enoxaparin, Lovenox, Sanofi-Aventis,
Paris, France) was injected intradermally every 12 h (1000
international unit anti-Xa) to prevent clotting. Mean outflow
was of 9.1 ml/h, with 1.6.10
6 cells/ml, and 0.7% of DC.
Dendritic cells collection and purification
Lymph was collected twice a day. Cells were step-frozen in FCS
containing 10% DMSO. Low-density lymph cells were obtained
after centrifugation on a 1.065 density iodixanol gradient
(Optiprep; Nycomed Pharma, Paris, France).
For FITC painting, FITC (Sigma, Saint-Quentin Fallavier
France) was resuspended at 1 mg/ml in acetone/dibutylphtalate
(V/V). The suspension was applied on the leg of the animal.
Lymph cells were collected 2 days later and stained as described
below.
Skin was obtained from swine undergoing surgical experiments.
Skin biopsies were sampled using 8 mm punches (Stiefel,
Wa ¨chtersbach, Germany). Skin biopsies were incubated overnight
at 4uC in complete RPMI plus Dispase (Invitrogen, Cergy
Pontoise, France). The next day biopsies, still in dispase, were
incubated 2 h at 37uC allowing the separation of dermis and
epidermis with tweezers. Epidermis and dermis were then
incubated overnight at 37uC in complete RPMI (plus Collagenase
D (Roche, Meylan, France) for dermis). Biopsies were filtered on
100 mm pores-nylon filters and cells were then processed for Facs
staining.
For TUNEL staining, collagenase digested dermal or epidermal
cells were first submitted to Ficoll, whereas lymph cells were
deposed on optiprep gradiant. Enriched skin and lymph DC were
then stained with anti-MHC-II (MSA3). Second step Miltenyi
(Paris, France) anti-mouse antibodies coupled to magnetic beads
were added, and cells were selected on column. MHC-II
pos cells
represented routinely more than 80% of the purified cells.
Antibodies and FACS Staining
The following antibodies were used: anti-CD1 (76-7-4), anti-
CD172a (74-22-15, 74-22-15a), anti-MHC-II (Th21a, MSA3),
anti-CD14 (CAM36) from VMRD (Pullmann, WA); anti-
CD11R3 (2F4/11), anti-CD16 (G7), unlabeled or PE-coupled
anti-CD163 (MCA2311) from AbDSerotec (Oxford, UK); anti-
CD206 (122D2.08) and biotinylated-anti-CD207 (929F3.01) from
Dendritics (Lyon, France); anti-CADM1 (3E1) from MBL
(Woburn, MA), anti-CD21 (B-ly4) from BD/Pharmingen (Le
Pont de Claix, France). The anti-CD209/DC-Sign is a kind gift
from X.J. Meng [32].
Matched isotype controls for mouse IgG1, IgG2b, IgG2a were
purchased from InVitrogen. Isotype controls for biotinylated rat-
IgG2a and PE-coupled IgG1 were from BD/Pharmingen. Isotype-
specific secondary reagents coupled to FITC, PE, Tricolor,
alexa647, streptavidine-alexa488 were from InVitrogen. Dead
cells were excluded by 7AAD (SIGMA) staining. Because 929F3
antibody recognizes an intracellular epitope, CD207 staining was
done using CalTag Fix&Perm following manufacturer instruction.
Cells were analyzed on a FACS-Calibur (BD/Pharmingen).
Immunohistological staining of skin samples
Skin biopsies were snap-frozen in OCT (Sakura, Paris, France)
and conserved at -80uC. Cryosections (5 mm) were cut using
cryotom (Leica CM3050S, Nanterre, France). Sections were air-
dried, fixed in cold methanol/acetone and stained using previously
described anti-swine antibodies and isotype-specific secondary
antibodies. Sections were mounted in SlowFade mounting
medium (InVitrogen). Slides were examined on a LSM510
confocal microscope (Zeiss, LePecq, France), using a 40X, oil
immersion objective.
TUNEL staining of skin and lymph cDC
Magnetically enriched MHC-II
pos DC were deposed on slide by
cytospin. Cells were air dried, fixed in 4%PFA before surface
staining using previously described antibodies. Tunel staining was
then processed according to manufacturer instruction (R&D, Lille,
France).
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